Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zavegepant nasal spray for acute treatment of migraine in Asian adults
CTR20232410Phase 3Completed
- Sponsor
- Pfizer
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zavegepant in migraine, sponsored by Pfizer. Started Aug 2023; status: completed.
02
Drugs
zavegepant
03
Conditions
migraine
Beyond the preview
Go deeper on CTR20232410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232410.